William Andrew Macan Net Worth

The estimated Net Worth of William Andrew Macan is at least $1.4 Milion dollars as of 28 February 2024. William Macan owns over 28,403 units of Neuronetics Inc stock worth over $288,106 and over the last 6 years William sold STIM stock worth over $1,111,443.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

William Macan STIM stock SEC Form 4 insiders trading

William has made over 20 trades of the Neuronetics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently William sold 28,403 units of STIM stock worth $88,333 on 28 February 2024.

The largest trade William's ever made was selling 34,991 units of Neuronetics Inc stock on 19 December 2023 worth over $87,128. On average, William trades about 7,625 units every 56 days since 2018. As of 28 February 2024 William still owns at least 389,333 units of Neuronetics Inc stock.

You can see the complete history of William Macan stock trades at the bottom of the page.

What's William Macan's mailing address?

William's mailing address filed with the SEC is C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355.

Insiders trading at Neuronetics Inc

Over the last 6 years, insiders at Neuronetics Inc have traded over $9,582,393 worth of Neuronetics Inc stock and bought 1,499,267 units worth $4,708,316 . The most active insiders traders include Capital Llc Cannell, Ronald Hunt oraz Glenn P Muir. On average, Neuronetics Inc executives and independent directors trade stock every 20 days with the average trade being worth of $21,199. The most recent stock trade was executed by Glenn P Muir on 5 September 2024, trading 25,000 units of STIM stock currently worth $20,000.

What does Neuronetics Inc do?

with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the first company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.

Complete history of William Macan stock trades at U.S. Silica Inc i Neuronetics Inc

Neuronetics Inc executives and stock owners

Neuronetics Inc executives and other stock owners filed with the SEC include:

• Daniel Guthrie,
  Chief Commercial Officer
• Stephen Furlong,
  Vice President, Chief Financial Officer, Office of the President
• Gregory Harper,
  Vice President - Product Development and Operations
• Keith J. Sullivan,
  Pres, CEO & Director
• Yelena Tropsha,
  Vice President - Commercial Access
• Stephen J. Furlong M.S.,
  Sr. VP, CFO & Treasurer
• W. Andrew Macan,
  Sr. VP, Gen. Counsel, Chief Compliance Officer, Sec. & Member of Office of the Pres
• Brian Farley,
  Independent Non-Executive Chairman of the Board
• Glenn Muir,
  Independent Director
• Wilfred Jaeger,
  Independent Director
• Sheryl Conley,
  Independent Director
• Mark Klausner,
  Managing Partner
• Bruce Shook,
  Independent Director
• John Bakewell,
  Director
• Sara Grubbs,
  Vice President of Sales
• W. Andrew Macan,
  Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary, Office of the President
• Keith Sullivan,
  President, Chief Executive Officer, Director
• Kara Thornton,
  VP of HR & Sr. Director
• Claire Sears,
  VP of Marketing
• Leaf Ventures Ii, L.P.New L...,
  
• Paulina Hill,
  Director
• Stephen M Campe,
  Director
• Ventures Ltd General Electr...,
  
• Ronald Hunt,
  Director
• Growth Capital, Llc Investor,
  10% owner
• Megan Rosengarten,
  
• Christopher Thatcher,
  President and CEO
• Peter Donato,
  Vice President and CFO
• Cheryl R Blanchard,
  Director
• Capital Llc Cannell,
  10% owner
• Joseph H Capper,
  Director
• Robert Cascella,